查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1970834

代谢检测市场－全球产业规模、份额、趋势、机会、预测：按产品、应用、地区和竞争对手划分，2021-2031年

Metabolic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球代谢检测市场预计将从 2025 年的 6.195 亿美元成长到 2031 年的 8.3066 亿美元，复合年增长率为 5.01%。

该领域涵盖诊断软体和设备，它们透过测量能量消耗和氧气消耗等指标来评估生理健康状况。市场成长的主要驱动力是慢性文明病疾病发生率的上升，以及代谢评估在健康计划和运动医学中日益普及。国际糖尿病联盟在2024年发布的报告强调了精准代谢分析工具的重要性，报告预测全球约有5.89亿成年人将患有糖尿病。

市场概览
预测期 2027-2031
市场规模：2025年 6.195亿美元
市场规模：2031年 8.3066亿美元
复合年增长率：2026-2031年 5.01%
成长最快的细分市场 身体组成分析
最大的市场 北美洲

儘管成长要素强劲，但市场仍面临许多障碍，例如先进检测设备成本高昂以及需要专业培训才能解读数据。这些经济和技术壁垒往往阻碍了新兴经济体的医疗机构和小规模诊所采用这些先进系统。因此，这些限制阻碍了代谢检测技术的广泛应用，并成为全球市场更广泛发展和扩张的主要障碍。

市场驱动因素

全球肥胖和糖尿病的日益普及是推动市场成长的主要因素，也因此迫切需要能够有效监测代谢健康并进行体重管理的先进诊断工具。随着METABOLIC INC.症候群成为全球性流行病，个人和医疗保健机构都越来越多地转向代谢检测，以製定个人化的健身和营养策略。文明病的增加使得人们即时需要获得关于基材利用和能量消耗的准确数据，以对抗慢性疾病。 2024年3月，世界肥胖联盟强调了问题的严重性，估计全球有超过10亿人肥胖。这意味着庞大的患者群体需要进行代谢干预。

同时，代谢监测设备的科技创新正在变革整个产业，将复杂的临床诊断转化为用户友好、易于使用的穿戴式装置。智慧戒指和连续血糖监测仪等设备能够即时追踪代谢指标，使用者群体也从精英运动员扩展到一般大众。这种向个人化数据分析和远端监测的转变，正为製造商带来巨大的商业性成功。例如，2024年10月，雅培公司报告称，其FreeStyle Libre连续血糖监测系统仅在第三季的销售额就超过16亿美元，实现了19.1%的成长率。此外，2024年3月，《展望商业》报道称，代谢追踪Start-UpsUltrahuman获得了3,500万美元的B轮资金筹措，用于扩大其研发和生产能力，凸显了该领域的蓬勃发展。

市场挑战

全球代谢检测市场成长的主要障碍在于先进检测设备及其操作所需的专业培训成本高昂。先进代谢测量设备所需的高额初始投资，对发展中地区的独立诊所、小规模医疗机构和医疗保健系统构成了巨大的进入门槛。因此，该市场主要局限于高端医院和资金雄厚的研究机构，这极大地限制了潜在市场规模，并阻碍了该技术在普通临床实践中的广泛应用。

聘用精通复杂代谢数据解读的专家所带来的营运成本，更加剧了医疗机构的财务负担。高昂的营运成本和资本成本的双重压力，迫使许多医疗机构管理者降低了这些诊断工具的优先顺序。这种财务保守主义也体现在近期的采购趋势中。根据美国医院协会 (AHA) 统计，94% 的医疗机构管理者预计到 2024 年将推迟设备升级，以应对日益增长的财务压力。这种普遍推迟资本投资的做法，直接阻碍了代谢检测市场的发展，抑制了尖端系统的采购，抵消了慢性文明病日益增长所带来的需求。

市场趋势

将人工智慧融入预测性代谢分析正在从根本上改变整个产业，使诊断方式从被动观察转变为动态疾病逆转模拟。先进的演算法正在产生“数位双胞胎”，以虚拟方式复製个体的代谢特征，从而预测个体对特定生活方式调整的生理反应。这项创新使医疗服务提供者能够超越传统的静态报告方法，推荐数据驱动的、可即时调整的精准干预措施。根据HLTH报道，为了支持这项技术进步，Twin Health于2025年8月资金筹措了5,300万美元，用于扩展其人工智慧驱动的「全身数位双胞胎」平台。该平台透过为每位成员提供个人化指导，帮助改善慢性代谢疾病。

同时，随着代谢为基础的精准营养理念的兴起，市场关注点正从临床糖尿病管理扩展到更广泛的健康促进和体重管理应用。製造商和监管机构正越来越多地核准连续代谢监测用于一般用途，使消费者能够利用即时血糖数据而非一般建议来调整饮食。这一趋势正在推动专门核准用于非医疗体重管理的设备商业化，使代谢检测有效地摆脱了对胰岛素的依赖。根据 MedTech Dive 于 2025 年 8 月报道，Signos 公司一款专为体重管理设计的血糖监测系统获得了 FDA 的核准，这标誌着一个重要的行业进展：向普通消费者市场提供易于获取的商业化代谢分析资讯。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球代谢检测市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品细分（CPET、身体组成分析、心电图、可携式系统）
    • 依应用领域（重症监护、文明病、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美代谢检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲代谢检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区代谢检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲代谢检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲代谢检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章 全球代谢侦测市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Becton, Dickinson and Company
  • General Electric Company
  • Geratherm Medical AG
  • MGC DIAGNOSTICS CORPORATION
  • OSI Systems, Inc.
  • CORTEX Biophysik GmbH
  • COSMED srl
  • KORR Medical Technology Inc.
  • Microlife Medical Home Solutions, Inc.
  • Parvomedics, Incorporated

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 24553

The Global Metabolic Testing Market is projected to expand from USD 619.50 Million in 2025 to USD 830.66 Million by 2031, registering a compound annual growth rate of 5.01%. This sector comprises diagnostic software and devices designed to evaluate physiological health by measuring metrics such as energy expenditure and oxygen consumption. Market growth is largely sustained by the rising incidence of chronic lifestyle-related diseases and the increasing adoption of metabolic assessments within wellness programs and sports medicine. Highlighting the critical need for accurate metabolic profiling tools, the International Diabetes Federation reported in 2024 that approximately 589 million adults worldwide were living with diabetes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 619.50 Million
Market Size 2031USD 830.66 Million
CAGR 2026-20315.01%
Fastest Growing SegmentBody Composition Analysis
Largest MarketNorth America

Despite these robust growth drivers, the market faces significant hurdles stemming from the substantial costs associated with sophisticated testing equipment and the necessity for specialized training to interpret the data. These financial and technical barriers often prevent healthcare institutions and smaller clinics in emerging economies from implementing these advanced systems. Consequently, these constraints restrict the accessibility of metabolic testing technologies and serve as a major impediment to the broader development and expansion of the global market.

Market Driver

The rising global prevalence of obesity and diabetes serves as a major market accelerator, creating an urgent demand for sophisticated diagnostic tools capable of supporting effective metabolic health monitoring and weight management. With metabolic syndrome emerging as a worldwide epidemic, both individuals and healthcare providers are increasingly turning to metabolic testing to customize fitness and nutritional strategies. This escalation in lifestyle-related conditions necessitates immediate access to precise data on substrate utilization and energy expenditure to combat chronic illnesses. The World Obesity Federation emphasized the scale of this issue in March 2024, estimating that over one billion people worldwide are living with obesity, representing a massive patient population in need of metabolic intervention.

Concurrently, technological innovations in metabolic testing devices are transforming the industry by evolving complex clinical diagnostics into user-friendly, accessible wearable formats. Devices such as smart rings and continuous glucose monitors now enable real-time tracking of metabolic indicators, expanding the user base from elite athletes to the general public. This transition toward personalized data analytics and remote monitoring has generated significant commercial success for manufacturers. For instance, Abbott reported in October 2024 that sales of its FreeStyle Libre continuous glucose monitoring system surpassed $1.6 billion in the third quarter alone, reflecting a 19.1 percent growth. Furthermore, Outlook Business noted in March 2024 that the metabolic tracking startup Ultrahuman secured $35 million in Series B funding to expand its research and manufacturing capabilities, underscoring the sector's vitality.

Market Challenge

A significant impediment to the growth of the Global Metabolic Testing Market is the prohibitive cost linked to sophisticated testing equipment and the specialized training required for its use. The high initial capital investment needed for advanced metabolic measurement devices establishes a formidable entry barrier for independent clinics, smaller medical facilities, and healthcare systems in developing regions. As a result, the market remains largely confined to premium hospitals and well-funded research institutions, which effectively limits the total addressable market and decelerates the adoption of this technology in general clinical practice.

This financial strain is further exacerbated by the operational expenses associated with hiring skilled professionals competent in interpreting complex metabolic data. The combined weight of high operational and capital costs compels many healthcare administrators to lower the priority of these diagnostic tools. This fiscal conservatism is reflected in recent procurement trends; according to the American Hospital Association, 94% of healthcare administrators in 2024 expected to delay equipment upgrades to navigate rising financial pressures. Such widespread postponement of capital investments directly impedes the metabolic testing market by stalling the purchase of modern systems, thereby counteracting the demand generated by the increase in chronic lifestyle diseases.

Market Trends

The integration of artificial intelligence for predictive metabolic analytics is fundamentally transforming the industry by shifting diagnostics from passive observation to dynamic, disease-reversing simulations. Sophisticated algorithms now facilitate the generation of "digital twins"-virtual representations of an individual's specific metabolism-that forecast physiological reactions to particular lifestyle adjustments. This innovation empowers providers to recommend precise, data-informed interventions that adjust in real-time, surpassing traditional static reporting methods. Underscoring this technological advancement, Twin Health raised $53 million in August 2025, as reported by HLTH, to expand its Whole Body Digital Twin platform, which utilizes AI to assist members in reversing chronic metabolic diseases through tailored guidance.

Simultaneously, the emergence of metabolically-driven precision nutrition is broadening the market's focus from clinical diabetes management to wider wellness and weight control applications. Manufacturers and regulatory agencies are increasingly validating continuous metabolic monitoring for general use, allowing consumers to refine their diets using real-time glycemic data instead of generic recommendations. This trend has resulted in the commercialization of devices specifically approved for non-medical weight management, effectively separating metabolic testing from insulin dependence. In a notable industry development reported by MedTech Dive in August 2025, Signos received FDA clearance for its glucose monitoring system designed specifically for weight management, signaling a major shift toward providing accessible, over-the-counter metabolic insights to the mass market.

Key Market Players

  • Becton, Dickinson and Company
  • General Electric Company
  • Geratherm Medical AG
  • MGC DIAGNOSTICS CORPORATION
  • OSI Systems, Inc.
  • CORTEX Biophysik GmbH
  • COSMED srl
  • KORR Medical Technology Inc.
  • Microlife Medical Home Solutions, Inc.
  • Parvomedics, Incorporated

Report Scope

In this report, the Global Metabolic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Metabolic Testing Market, By Product

  • CPET
  • Body Composition Analysis
  • ECG
  • Portable System

Metabolic Testing Market, By Application

  • Critical Care
  • Lifestyle Diseases
  • Others

Metabolic Testing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Metabolic Testing Market.

Available Customizations:

Global Metabolic Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Metabolic Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (CPET, Body Composition Analysis, ECG, Portable System)
    • 5.2.2. By Application (Critical Care, Lifestyle Diseases, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Metabolic Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Metabolic Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Metabolic Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Metabolic Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Metabolic Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Metabolic Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. France Metabolic Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Metabolic Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Metabolic Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Metabolic Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia Pacific Metabolic Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Metabolic Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Metabolic Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Metabolic Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Metabolic Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Metabolic Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. Middle East & Africa Metabolic Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Metabolic Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Metabolic Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Metabolic Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. South America Metabolic Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Metabolic Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Metabolic Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Metabolic Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Metabolic Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton, Dickinson and Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. General Electric Company
  • 15.3. Geratherm Medical AG
  • 15.4. MGC DIAGNOSTICS CORPORATION
  • 15.5. OSI Systems, Inc.
  • 15.6. CORTEX Biophysik GmbH
  • 15.7. COSMED srl
  • 15.8. KORR Medical Technology Inc.
  • 15.9. Microlife Medical Home Solutions, Inc.
  • 15.10. Parvomedics, Incorporated

16. Strategic Recommendations

17. About Us & Disclaimer